(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
0.00% $ 72.50
Live Chart Being Loaded With Signals
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 100.00 |
Średni wolumen | 25.00 |
Kapitalizacja rynkowa | 64.80M |
EPS | $0 ( 2024-04-22 ) |
Last Dividend | $0.500 ( 2023-10-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 11.80 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2011-10-14 | Williams Frank E Jr | Sell | 0 | Bioqual |
INSIDER POWER |
---|
0.00 |
Last 1 transactions |
Buy: 0 | Sell: 0 |
Bioqual, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Bioqual, Inc. Finanse
Annual | 2022 |
Przychody: | $62.66M |
Zysk brutto: | $8.64M (13.80 %) |
EPS: | $0.930 |
FY | 2022 |
Przychody: | $62.66M |
Zysk brutto: | $8.64M (13.80 %) |
EPS: | $0.930 |
FY | 2018 |
Przychody: | $35.88M |
Zysk brutto: | $8.73M (24.31 %) |
EPS: | $4.10 |
FY | 2017 |
Przychody: | $36.60M |
Zysk brutto: | $9.90M (27.06 %) |
EPS: | $4.44 |
Financial Reports:
No articles found.
Bioqual, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$1.000 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.500 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0700 | 2004-09-02 |
Last Dividend | $0.500 | 2023-10-05 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-27 | |
Next Payout Date | N/A | |
# dividends | 19 | -- |
Total Paid Out | $7.96 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.75 | -- |
Div. Sustainability Score | 9.38 | |
Div.Growth Potential Score | 4.38 | |
Div. Directional Score | 6.88 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TTNDF | Ex Dividend Knight | 2023-08-29 | Annually | 0 | 0.00% | |
IVSBF | Ex Dividend Knight | 2023-11-03 | Annually | 0 | 0.00% | |
BDORY | Ex Dividend Knight | 2023-09-12 | Bi-Monthly | 0 | 0.00% | |
RBSFY | Ex Dividend Knight | 2023-06-09 | Annually | 0 | 0.00% | |
EMSHF | Ex Dividend Knight | 2023-08-15 | Annually | 0 | 0.00% | |
VWAPY | Ex Dividend Junior | 2023-05-11 | Annually | 0 | 0.00% | |
KTHN | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
CBCFF | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
SEBC | Ex Dividend Junior | 2023-08-30 | Quarterly | 0 | 0.00% | |
FOTB | Ex Dividend Junior | 2023-05-31 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0152 | 1.500 | 9.70 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0163 | 1.200 | 9.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0249 | 1.500 | -0.834 | -1.251 | [0.1 - 1] |
payoutRatioTTM | 0.467 | -1.000 | 5.33 | -5.33 | [0 - 1] |
currentRatioTTM | 4.22 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.02 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.573 | 1.500 | 2.37 | 3.55 | [0.2 - 2] |
debtRatioTTM | 0.0600 | -1.500 | 9.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.20 | 2.00 | 6.60 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 8.87 | 2.00 | 5.57 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0910 | -1.500 | 9.64 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.141 | 1.000 | -0.978 | -0.978 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0145 | 1.000 | -1.711 | -1.711 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.58 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.068 | 0.800 | 6.21 | 4.97 | [0.5 - 2] |
Total Score | 9.38 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 67.76 | 1.000 | 3.26 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0249 | 2.50 | -0.536 | -1.251 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 8.87 | 2.00 | 7.04 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.690 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.20 | 2.00 | 6.60 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.467 | 1.500 | 5.33 | -5.33 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.145 | 1.000 | 8.87 | 0 | [0.1 - 0.5] |
Total Score | 4.38 |
Bioqual, Inc.
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej